39259503|t|The NRF2 inducer CDDO-2P-Im provokes a reduction in amyloid beta levels in Alzheimer's disease model mice.
39259503|a|Alzheimer's disease (AD) is the most common etiology of dementia. The transcription factor NF-E2-related factor 2 (NRF2) induces the expression of genes encoding phase II detoxification and antioxidant genes. NRF2 is regulated by Kelch-like ECH-associated protein 1 (KEAP1), and the KEAP1-NRF2 system is the key regulatory system involved in cytoprotection. To examine whether pharmacological induction of NRF2 expression alleviates AD phenotypes in vivo, we employed two AD mouse models, i.e., App  NL-G-F/NL-G-F (AppNLGF) and APPV717I::TAUP301L (APP/TAU) mice. As the synthetic oleanane triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11-dien-28-oyl)] (CDDO)-4(-pyridin-2-yl)-imidazole (CDDO-2P-Im) exhibits strong NRF2-inducing activity, we treated AD model mice with CDDO-2P-Im. We found that Abeta42 levels were markedly greater in the brains of AppNLGF mice than in those of APP/TAU mice. CDDO-2P-Im treatment significantly decreased Abeta42 levels, but not Abeta40 levels, in APP/TAU mice. Consequently, CDDO-2P-Im also decreased the ratio of Abeta42/Abeta40, a vital marker of amyloid plaque formation. LC-MS/MS analyses revealed that CDDO-2P-Im was delivered to the brains of the APP/TAU mice. CDDO-2P-Im induced the expression of detoxification and antioxidant gene targets of NRF2 and elevated reduced glutathione (GSH) levels in the mouse brain. These results support the notion that CDDO-2P-Im ameliorates AD-related pathologic changes.
39259503	4	8	NRF2	Gene	18024
39259503	17	27	CDDO-2P-Im	Chemical	-
39259503	75	94	Alzheimer's disease	Disease	MESH:D000544
39259503	101	105	mice	Species	10090
39259503	107	126	Alzheimer's disease	Disease	MESH:D000544
39259503	128	130	AD	Disease	MESH:D000544
39259503	163	171	dementia	Disease	MESH:D003704
39259503	198	220	NF-E2-related factor 2	Gene	18024
39259503	222	226	NRF2	Gene	18024
39259503	316	320	NRF2	Gene	18024
39259503	337	372	Kelch-like ECH-associated protein 1	Gene	50868
39259503	374	379	KEAP1	Gene	50868
39259503	390	395	KEAP1	Gene	50868
39259503	396	400	NRF2	Gene	18024
39259503	513	517	NRF2	Gene	18024
39259503	540	542	AD	Disease	MESH:D000544
39259503	579	581	AD	Disease	MESH:D000544
39259503	582	587	mouse	Species	10090
39259503	635	643	APPV717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:9606;CA#:127791
39259503	648	653	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;OriginalGene:18024;CorrespondingGene:4780;CorrespondingSpecies:10090
39259503	664	668	mice	Species	10090
39259503	687	708	oleanane triterpenoid	Chemical	-
39259503	709	791	1-[2-cyano-3,12-dioxooleana-1,9(11-dien-28-oyl)] (CDDO)-4(-pyridin-2-yl)-imidazole	Chemical	-
39259503	793	803	CDDO-2P-Im	Chemical	-
39259503	821	825	NRF2	Gene	18024
39259503	856	858	AD	Disease	MESH:D000544
39259503	865	869	mice	Species	10090
39259503	875	885	CDDO-2P-Im	Chemical	-
39259503	963	967	mice	Species	10090
39259503	993	997	mice	Species	10090
39259503	999	1009	CDDO-2P-Im	Chemical	-
39259503	1095	1099	mice	Species	10090
39259503	1115	1125	CDDO-2P-Im	Chemical	-
39259503	1189	1203	amyloid plaque	Disease	MESH:D058225
39259503	1247	1257	CDDO-2P-Im	Chemical	-
39259503	1301	1305	mice	Species	10090
39259503	1307	1317	CDDO-2P-Im	Chemical	-
39259503	1391	1395	NRF2	Gene	18024
39259503	1417	1428	glutathione	Chemical	MESH:D005978
39259503	1430	1433	GSH	Chemical	MESH:D005978
39259503	1449	1454	mouse	Species	10090
39259503	1500	1510	CDDO-2P-Im	Chemical	-
39259503	1523	1525	AD	Disease	MESH:D000544
39259503	Association	18024	50868

